Skip to main content
FinSpry Logo
FinSpry
CTSO logo
CTSO
(NASDAQ)
Cytosorbents Corporation
$0.36-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Cytosorbents (CTSO) Stock Price & Financial Analysis

Cytosorbents Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.36 - $0.40
52-Week High$1.22
52-Week Low$0.35
Open$0.40
Volume38.13K
Average Volume (3M)191.00K
Market Cap22.67M
Shares Outstanding62.74M
Price to Sales (P/S)0.61
Price to Book (P/B)10.33
EV/EBITDA-2.64
Revenue (TTM)37.20M
Net Income (TTM)-11.85M
Free Cash Flow (TTM)-10.51M
EPS (TTM)$-0.19
Profit Margin-31.85%
Operating Margin-36.01%
Return on Equity (ROE)-540.06%
Debt to Equity8.64
50-Day MA$0.44
200-Day MA$0.63
52-Week Change-64.57%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Cytosorbents

What is the current stock price for CTSO?

As of the latest trading session, CTSO stock trades at $0.36. The 52-week range is $0.35–$1.22, with a day range of $0.36–$0.40.

What is the P/E ratio for CTSO?

The P/E ratio (Price-to-Earnings) for CTSO is shown in the Key Statistics section. This valuation metric helps compare Cytosorbents Corporation to industry peers.

Does CTSO pay dividends?

Cytosorbents does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CTSO?

Analyst ratings and recommendations for CTSO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of CTSO?

Cytosorbents's market capitalization is $22.7M, classifying it as a micro-cap company. Cytosorbents operates in the Healthcare sector within the Medical Devices industry.